Lung Cancer

ASCO 2022: Updates in Lung Cancer

The American Society of Clinical Oncology Annual Meeting 2022 brought together thousands of experts in oncology to hear new data…

Date: 24th June 2022

ASCO 2022 Daily Round-Ups: Day 2

Catch up on our highlights from Day 2 of ASCO 2022! We spoke to Joaquim Bellmunt, Robert Jones, Miguel Garcia-Pardo,…

Date: 4th June 2022

ASCO 2022 Daily Round-Ups: Day 1

Catch up on our highlights from Day 1 of ASCO 2022!   We spoke to Alexander Spira, Jia Luo, Paolo…

Date: 4th June 2022

Updates in radiation oncology from ESTRO 2022

This year’s European Society for Radiotherapy and Oncology (ESTRO) annual congress took place in Copenhagen, Denmark, from 6-10 May 2022,…

Date: 27th May 2022

Lung Cancer Screening: Current state and future directions

Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly…

Date: 1st April 2022

BTOG 2022: Highlights in lung cancer

For patients with lung cancer, surgical resection is a treatment option and perioperative management is imperative to improve surgical outcomes….

Date: 11th February 2022

The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC

The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…

Date: 25th November 2021

ISLB 2021: Current standards and future directions for liquid biopsy

Liquid biopsy is an exciting field, with many promising advances in recent years. In this podcast, we cover a range…

Date: 12th November 2021

The Lung Cancer Sessions: Highlights from ASCO 2021

Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer…

Date: 7th October 2021

ASCO 2021: Immunotherapy updates in lung cancer

Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune…

Date: 4th August 2021

The Lung Cancer Sessions: Highlights from BTOG 2021

VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented…

Date: 22nd June 2021

BTOG 2021: KRAS targeting and oncogenically-driven lung cancer

Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK…

Date: 12th May 2021

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter